Cardiac angiosarcoma responding to multidisciplinary treatment.
Early detection of cardiac angiosarcoma is usually difficult and the prognosis is very poor. We experienced a 32-year-old man with cardiac angiosarcoma who responded to multidisciplinary treatment with recombinant interleukin-2, postoperative chemotherapy (cyclophosphamide, vincristine, doxorubicin, Dacarbazine) and radiation. At 30 months after surgery, there was no evidence of recurrence or metastasis in spite of incomplete resection.
Kakizaki
S
S
Department of Gastroenterology, Maebashi Red Cross Hospital, Gunma, Japan. kakizaki@sb.gunma-u.ac.jp
Takagi
H
H
Hosaka
Y
Y
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002305:Cardiac Tamponade; D017024:Chemotherapy, Adjuvant; D017023:Coronary Angiography; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000627:therapeutic use; D003606:Dacarbazine / Q000008:administration & dosage / Q000627:therapeutic use; D004317:Doxorubicin / Q000008:administration & dosage / Q000627:therapeutic use; D004452:Echocardiography; D006338:Heart Neoplasms / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D006394:Hemangiosarcoma / Q000175:diagnosis / Q000601:surgery / Q000628:therapy*; D006801:Humans; D007376:Interleukin-2 / Q000627:therapeutic use; D008279:Magnetic Resonance Imaging; D008297:Male; D018714:Radiotherapy, Adjuvant; D011994:Recombinant Proteins / Q000627:therapeutic use; D014750:Vincristine / Q000008:administration & dosage / Q000627:therapeutic use
D007376:Interleukin-2; D011994:Recombinant Proteins; D014750:Vincristine; D003606:Dacarbazine; D004317:Doxorubicin; D003520:Cyclophosphamide